Healionics announces 12-month clinical results for STARgraft
SEATTLE, WA, USA, August 7, 2024 /EINPresswire.com/ -- Healionics Corporation, a developer of synthetic biomaterial-based medical devices, today announced 12-month clinical results in the ongoing human trial of its STARgraft arteriovenous (AV) graft ( …